SLDB: Brooks Gabriel sold $25K of stock
By AlphaYouPublished Form 4
Brooks Gabriel
Reporting filer
Brooks Gabriel reported selling 4,374 shares of Solid Biosciences Inc. for about $25K ($5.62 a share on average). Form 4 filed Oct 20, 2026 lists 3 entries.
See the price move since this trade →
- Disclosed
- Oct 20, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Brooks Gabriel | 2026-10-18 | M | Exercise or conversion | 9750 | Not stated (see footnotes) | 101,615 | 2 days | Filed terms
|
| Common Stock | Brooks Gabriel | 2026-10-19 | S | Sale | 4374 | 5.62 | 97,241 | 1 day | Filed terms
|
| Restricted Stock Units (derivative) | Brooks Gabriel | 2026-10-18 | M | Exercise or conversion | 9750 | 0 | 9,750 | 2 days | Filed terms
|
Common Stock
- Owner
- Brooks Gabriel
- Date
- 2026-10-18
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 9750
- Price
- Not stated (see footnotes)
- Following holdings
- 101,615
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-18
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- transaction Shares: 9750
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 101615
- id: F2
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Brooks Gabriel
- Date
- 2026-10-19
- Code
- S
- Action
- Sale
- Quantity
- 4374
- Price
- 5.62
- Following holdings
- 97,241
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-19
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- transaction Shares: 4374
- id: F3
- transaction Price Per Share: 5.62
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 97241
- direct Or Indirect Ownership: D
Restricted Stock Units (derivative)
- Owner
- Brooks Gabriel
- Date
- 2026-10-18
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 9750
- Price
- 0
- Following holdings
- 9,750
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Restricted Stock Units
- id: F1
- transaction Date: 2026-10-18
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- transaction Shares: 9750
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F4
- id: F4
- underlying Security Title: Common Stock
- underlying Security Shares: 9750
- shares Owned Following Transaction: 9750
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Brooks Gabriel: Chief Medical Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- F2: Includes 2,399 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 29, 2026.
- F3: This sale was made to cover withholding taxes following the vesting of previously granted RSUs pursuant to a durable automatic sale instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks.
- F4: The RSUs were granted on October 18, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.
Original sources
Prepared automatically from public filing data. Report a correction.